Artemis Investment Management LLP - BIOXCEL THERAPEUTICS INC ownership

BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 98 filers reported holding BIOXCEL THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.24 and the average weighting 0.0%.

Quarter-by-quarter ownership
Artemis Investment Management LLP ownership history of BIOXCEL THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$5,954,582
-67.4%
895,048
-8.8%
0.07%
-67.0%
Q1 2023$18,278,606
-36.4%
981,472
-26.4%
0.22%
-31.3%
Q4 2022$28,748,877
+76.8%
1,333,691
-3.0%
0.33%
+76.2%
Q3 2022$16,260,000
-11.2%
1,374,496
-0.8%
0.18%
-1.6%
Q2 2022$18,310,000
-38.7%
1,384,938
-3.0%
0.19%
-21.3%
Q1 2022$29,855,000
+4.4%
1,428,228
+1.3%
0.24%
+14.9%
Q4 2021$28,604,000
-31.7%
1,410,382
+2.2%
0.21%
-37.3%
Q3 2021$41,892,000
+20.9%
1,380,260
+15.7%
0.33%
+11.0%
Q2 2021$34,664,000
-21.9%
1,193,290
+15.6%
0.30%
-29.0%
Q1 2021$44,397,000
-5.2%
1,031,864
+1.8%
0.42%
-13.9%
Q4 2020$46,839,000
+8.0%
1,013,448
+1.2%
0.49%
-10.3%
Q3 2020$43,383,000
-20.6%
1,001,708
-32.7%
0.54%
+564.6%
Q2 2020$54,660,000
+57.3%
1,488,456
-5.4%
0.08%
+54.7%
Q1 2020$34,754,000
+124.1%
1,573,916
+46.6%
0.05%
-73.0%
Q4 2019$15,508,000
+85.4%
1,073,591
-9.8%
0.20%
+71.9%
Q3 2019$8,365,000
-21.4%
1,190,184
+21.6%
0.11%
-9.5%
Q2 2019$10,644,000
+10.1%
979,015
+1.0%
0.13%
+12.5%
Q1 2019$9,668,000
+114.8%
968,979
-16.7%
0.11%
+89.8%
Q4 2018$4,501,000
-53.6%
1,163,013
-7.3%
0.06%
-45.4%
Q3 2018$9,700,000
-14.5%
1,254,853
+1.3%
0.11%
-30.3%
Q2 2018$11,351,000
-7.2%
1,238,495
+2.3%
0.16%
-18.0%
Q1 2018$12,237,0001,210,4350.19%
Other shareholders
BIOXCEL THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Logos Global Management LP 430,000$19,866,0001.70%
APIS CAPITAL ADVISORS, LLC 20,000$924,0000.89%
Avidity Partners Management LP 547,000$25,271,0000.82%
Knoll Capital Management, LLC 20,000$924,0000.63%
Artemis Investment Management LLP 1,013,448$46,839,0000.49%
AlphaCentric Advisors LLC 25,000$1,155,0000.48%
First Light Asset Management, LLC 94,202$4,352,0000.32%
Ikarian Capital, LLC 150,000$6,930,0000.31%
Longitude (Cayman) Ltd. 8,000$370,0000.18%
AllSquare Wealth Management LLC 5,490$254,0000.17%
View complete list of BIOXCEL THERAPEUTICS INC shareholders